Blueprint Medicines Corp
NASDAQ:BPMC

Watchlist Manager
Blueprint Medicines Corp Logo
Blueprint Medicines Corp
NASDAQ:BPMC
Watchlist
Price: 94.57 USD -1.46% Market Closed
Market Cap: 6B USD
Have any thoughts about
Blueprint Medicines Corp?
Write Note

Wall Street
Price Targets

BPMC Price Targets Summary
Blueprint Medicines Corp

Wall Street analysts forecast BPMC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BPMC is 128.09 USD with a low forecast of 81.81 USD and a high forecast of 175.35 USD.

Lowest
Price Target
81.81 USD
13% Downside
Average
Price Target
128.09 USD
35% Upside
Highest
Price Target
175.35 USD
85% Upside

BPMC Last Price Targets
Blueprint Medicines Corp

The latest public price target was made on Oct 31, 2024 by Ami Fadia from Needham , who expects BPMC stock to rise by 43% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Ami Fadia
Needham
135 USD
Upside 43%
1 month ago
Oct 31, 2024
Blueprint Medicines (BPMC) PT Raised to $135 at Needham
StreetInsider
David Dai
UBS
88 USD
Downside 7%
1 month ago
Oct 24, 2024
UBS Starts Blueprint Medicines (BPMC) at Neutral
StreetInsider
Bradley Canino
Stifel Nicolaus
155 USD
Upside 64%
2 months ago
Sep 19, 2024
Stifel on Blueprint Medicines (BPMC): 'We think fear around Ayvakit's growth offers an attractive entry point that may not last'
StreetInsider
Matthew Biegler
Oppenheimer
130 USD
Upside 37%
4 months ago
Aug 1, 2024
Blueprint Medicines price target raised to $130 from $125 at Oppenheimer
TheFly
Peter Lawson
Barclays
105 USD
Upside 11%
4 months ago
Jul 29, 2024
Blueprint Medicines price target raised to $105 from $75 at Barclays
TheFly
Matthew Biegler
Oppenheimer
125 USD
Upside 32%
5 months ago
Jul 8, 2024
Blueprint Medicines (BPMC) PT Raised to $125 at Oppenheimer
StreetInsider
Andrew Berens
Leerink Partners
97 USD
Upside 3%
7 months ago
May 6, 2024
Leerink Partners Upgrades Blueprint Medicines (BPMC) to Market Perform
StreetInsider
Christopher Raymond
Raymond James
104 USD
Upside 10%
7 months ago
May 3, 2024
Blueprint Medicines (BPMC) PT Raised to $104 at Piper Sandler
StreetInsider
Andrew Fein
H.C. Wainwright
135 USD
Upside 43%
7 months ago
May 3, 2024
Blueprint Medicines price target raised to $135 from $125 at H.C. Wainwright
TheFly
Show More Price Targets
Show Less Price Targets
Ami Fadia
Needham
Price Target 135 USD
Upside/Downside 43%
View Source
David Dai
UBS
Price Target 88 USD
Upside/Downside 7%
View Source
Bradley Canino
Stifel Nicolaus
Price Target 155 USD
Upside/Downside 64%
View Source
Matthew Biegler
Oppenheimer
Price Target 130 USD
Upside/Downside 37%
View Source
Peter Lawson
Barclays
Price Target 105 USD
Upside/Downside 11%
View Source
Matthew Biegler
Oppenheimer
Price Target 125 USD
Upside/Downside 32%
View Source
Andrew Berens
Leerink Partners
Price Target 97 USD
Upside/Downside 3%
View Source
Christopher Raymond
Raymond James
Price Target 104 USD
Upside/Downside 10%
View Source
Andrew Fein
H.C. Wainwright
Price Target 135 USD
Upside/Downside 43%
View Source
Show More Price Targets
Show Less Price Targets
Blueprint Medicines Corp Competitors:
Price Targets
4587
PeptiDream Inc
23% Upside
SANA
Sana Biotechnology Inc
314% Upside
VCEL
Vericel Corp
9% Upside
145020
Hugel Inc
54% Upside
DVAX
Dynavax Technologies Corp
89% Upside
AUPH
Aurinia Pharmaceuticals Inc
21% Upside
AMGN
Amgen Inc
21% Upside
RXRX
Recursion Pharmaceuticals Inc
22% Upside

Revenue
Forecast

Revenue Estimate
Blueprint Medicines Corp

For the last 8 years the compound annual growth rate for Blueprint Medicines Corp's revenue is 47%. The projected CAGR for the next 3 years is 57%.

47%
Past Growth
57%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Blueprint Medicines Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Blueprint Medicines Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-29%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BPMC's stock price target?
Price Target
128.09 USD

According to Wall Street analysts, the average 1-year price target for BPMC is 128.09 USD with a low forecast of 81.81 USD and a high forecast of 175.35 USD.

What is Blueprint Medicines Corp's Revenue forecast?
Projected CAGR
57%

For the last 8 years the compound annual growth rate for Blueprint Medicines Corp's revenue is 47%. The projected CAGR for the next 3 years is 57%.

Back to Top